• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

  • Axis Clinicals USA

Axis Clinicals

Contract Research Organization

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report

Accreditations

You are here: Home / Accreditations

National/International Accreditations

AXIS Clinicals has been audited and approved by various regulatory authorities that include:

  • Drugs Controller General of India
  • US-FDA
  • EMEA
  • UK-MHRA
  • AFSSAPS, France
  • ANVISA, Brazil
  • MCC, South Africa
  • MOH, Turkey
  • MOH, Mexico
  • Thailand FDA
  • WHO
  • GCC-DR ( Gulf Central Committee for Drug Registration)
  • NPRA Malaysia
  • AEMPS Spain
  • INFARMED Portugal

Medical Diagnostic Lab of AXIS Clinicals has been approved and accredited by NABL on annual basis. Besides study submissions to more than 25 countries, AXIS Clinicals has also been approved for submission of studies to MOH Canada, NPCB Malaysia, Australia, South Africa and WHO.

Primary Sidebar

Menu

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report

Footer

  • About Us
  • Our DNA
  • Our Core Values
  • Your Preferred Partner of Choice
  • Our Focus
  • Our Leadership
  • Accreditations
  • Global Locations
  • Services
  • BA | BE Studies
  • PK | PD and Patient Studies
  • Bio-Analytical Services
  • Phase II-IV
  • Project Management
  • PK | Biostatistics & Programming
  • Medical Writing
  • Regulatory Services
  • Quality Assurance and Compliance
  • Clinical Data Management
  • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us

Copyright © 2023 ยท Axis Clinicals